Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

SATELLOS BIOSCIENCE INC. (MSLE)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 5
  • 1 comments

Satellos to Present Clinical Program Updates at ICNMD 2026

Market reaction Comment Full text

AGENUS INC (AGEN)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 3
  • 1 comments

Agenus Announces Three-Year Survival Data from Phase 1b BOT+BAL Study in MSS Metastatic Colorectal Cancer to be Presented at ESMO GI 2026

Market reaction Comment Full text

SATELLOS BIOSCIENCE INC. (MSCLF)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 4
  • 1 comments

Satellos to Present Clinical Program Updates at ICNMD 2026

Market reaction Comment Full text

TILRAY BRANDS, INC. (TLRY)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 3
  • 1 comments

Montauk Brewing Kicks Off Summer with 14th Anniversary Celebration, Limited Brew Barn Release and Beach Cleanup

Market reaction Comment Full text

ATEA PHARMACEUTICALS, INC. (AVIR)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 6
  • 1 comments

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Market reaction Comment Full text

TD SYNNEX CORP (SNX)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 5
  • 1 comments

TD SYNNEX Reports Record Fiscal 2026 Second Quarter Results

Market reaction Comment Full text

CONSTELLATION ENERGY CORP (CEG)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 5
  • 1 comments

Constellation Announces Extension of Expiration for Exchange Offers

Market reaction Comment Full text

HIGHLANDER SILVER CORP. (HSLV)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 5
  • 1 comments

Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani

Market reaction Comment Full text

KYMERA THERAPEUTICS, INC. (KYMR)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 4
  • 1 comments

Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026

Market reaction Comment Full text

BAKER HUGHES CO (BKR)

  • Business News
  • June 25, 2026, 11:00 UTC
  • 4
  • 1 comments

Baker Hughes to Deliver Subsea Production Systems to Support Azule Energy’s Greater PAJ Development

Market reaction Comment Full text
  • Previous
  • 3429
  • 3430
  • 3431
  • 3432
  • 3433
  • Next

Search

News categories

  • Technical Exchange News(14539)
  • Event(6229)
  • SEC News(382944)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(234248)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin